High C5a levels are associated with increased mortality in sepsis patients - No enhancing effect by actin-free Gc-globulin

Clinical Biochemistry

Volumn 41, Issue 12, 2008, Pages 974-980

  Gressner, Olav A ^a   Koch, Alexander ^a   Sanson, Edouard ^a   Trautwein, Christian ^a   Tacke, Frank ^a  

^a UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

Author keywords

Actin free Gc globulin; C5a; Prognosis; Sepsis

Indexed keywords

ACTIN; COMPLEMENT COMPONENT C5A; VITAMIN D BINDING PROTEIN;

ADULT; AGED; ANALYTICAL PARAMETERS; ARTICLE; BLOOD ANALYSIS; CLINICAL ASSESSMENT; COMPLEMENT BLOOD LEVEL; CONTROLLED STUDY; CRITICALLY ILL PATIENT; DIAGNOSTIC VALUE; FEMALE; FOLLOW UP; HEMOCONCENTRATION; HOSPITAL ADMISSION; HUMAN; INFLAMMATION; INTENSIVE CARE UNIT; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; PROTEIN PROTEIN INTERACTION; SEPSIS;

ACTINS; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; BIOLOGICAL MARKERS; COMPLEMENT C5A; FEMALE; HUMANS; INTENSIVE CARE UNITS; MALE; MIDDLE AGED; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; ROC CURVE; SEPSIS; STATISTICS, NONPARAMETRIC; VITAMIN D-BINDING PROTEIN;

EID: 47049120122     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2008.05.005     Document Type: Article

References (25)

1. Janeway C.A.J., Travers P., Walport M., and Shlomchik M.J. The complement system. Immunobiology. 5th ed (2001), Garland Science, London
2. Ward P.A. The dark side of C5a in sepsis. Nat Rev Immunol. 4 (2004) 133-142
3. McLeod J.F., and Cooke N.E. The vitamin D-binding protein, alpha-fetoprotein, albumin multigene family: detection of transcripts in multiple tissues. J Biol Chem 264 (1989) 21760-21769
4. Meier U., Gressner O., Lammert F., and Gressner A.M. Gc-globulin: roles in response to injury. Clin Chem 52 (2006) 1247-1253
5. Lee W.M., and Galbraith R.M. The extracellular actin-scavenger system and actin toxicity. N Engl J Med 326 (1992) 1335-1341
6. Zhang J., and Kew R.R. Identification of a region in the vitamin D-binding protein that mediates its C5a chemotactic cofactor function. J Biol Chem 279 (2004) 53282-53287
7. Perez H.D. Gc globulin (vitamin D-binding protein) increases binding of low concentrations of C5a des Arg to human polymorphonuclear leukocytes: an explanation for its cochemotaxin activity. Inflammation 18 (1994) 215-220
8. McVoy L.A., and Kew R.R. CD44 and annexin A2 mediate the C5a chemotactic cofactor function of the vitamin D binding protein. J Immunol 175 (2005) 4754-4760
9. Rescher U., and Gerke V. Annexins-unique membrane binding proteins with diverse functions. J Cell Sci 117 (2004) 2631-2639
10. Pure E., and Cuff C.A. A crucial role for CD44 in inflammation. Trends Mol Med 7 (2001) 213-221
11. Piquette C.A., Robinson-Hill R., and Webster R.O. Human monocyte chemotaxis to complement-derived chemotaxins is enhanced by Gc-globulin. J Leukoc Biol 55 (1994) 349-354
12. Kew R.R., and Webster R.O. Gc-globulin (vitamin D-binding protein) enhances the neutrophil chemotactic activity of C5a and C5a des Arg. J Clin Invest 82 (1988) 364-369
13. Dellinger R.P., Levy M.M., Carlet J.M., et al. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med 36 (2008) 296-327
14. Knaus W.A., Draper E.A., Wagner D.P., and Zimmerman J.E. APACHE II: a severity of disease classification system. Crit Care Med 13 (1985) 818-829
15. Yagmur E., Weiskirchen R., Gressner A.M., Trautwein C., and Tacke F. Insulin resistance in liver cirrhosis is not associated with circulating retinol-binding protein 4. Diabetes Care 30 (2007) 1168-1172
16. Tacke F., Fiedler K., von Depka M., et al. Clinical and prognostic role of plasma coagulation factor XIII activity for bleeding disorders and 6-year survival in patients with chronic liver disease. Liver Int 26 (2006) 173-181
17. Gressner O., Meier U., Hillebrandt S., H EW, Kohl J., Sauerbruch T., and Lammert F. Gc-globulin concentrations and C5 haplotype-tagging polymorphisms contribute to variations in serum activity of complement factor C5. Clin Biochem 40 (2007) 771-775
18. Tacke F., Fiedler K., and Trautwein C. A simple clinical score predicts high risk for upper gastrointestinal hemorrhages from varices in patients with chronic liver disease. Scand J Gastroenterol 42 (2007) 374-382
19. Meier U., Gressner O., Lammert F., and Gressner A.M. Gc-globulin: roles in response to injury. Clin Chem 52 (2006) 1247-1253
20. von Landenberg P., and Shoenfeld Y. New approaches in the diagnosis of sepsis. Isr Med Assoc J. 3 (2001) 439-442
21. Dellinger R.P., Carlet J.M., Masur H., et al. Surviving sepsis campaign guidelines for management of severe sepsis and septic shock. Crit Care Med 32 (2004) 858-873
22. Nakae H., Endo S., Inada K., and Yoshida M. Chronological changes in the complement system in sepsis. Surg Today 26 (1996) 225-229
23. Riedemann N.C., Guo R.F., Bernacki K.D., et al. Regulation by C5a of neutrophil activation during sepsis. Immunity 19 (2003) 193-202
24. Aird W.C. The role of the endothelium in severe sepsis and multiple organ dysfunction syndrome. Blood 101 (2003) 3765-3777
25. Laudes I.J., Chu J.C., Sikranth S., et al. Anti-c5a ameliorates coagulation/fibrinolytic protein changes in a rat model of sepsis. Am J Pathol 160 (2002) 1867-1875